These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1148 related items for PubMed ID: 9068463

  • 1. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Robinson M, McFarland M, Sabesin S, Lehman GA, Castell D.
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [Abstract] [Full Text] [Related]

  • 2. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M, Harford WV, Fisher RS, Sampliner RE, Murray SB, Greski-Rose PA, Jennings DE.
    Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
    [Abstract] [Full Text] [Related]

  • 3. Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies.
    Howden CW, Henning JM, Huang B, Lukasik N, Freston JW.
    Am J Gastroenterol; 2001 Jun; 96(6):1704-10. PubMed ID: 11419818
    [Abstract] [Full Text] [Related]

  • 4. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
    Richter JE, Campbell DR, Kahrilas PJ, Huang B, Fludas C.
    Arch Intern Med; 2000 Jun 26; 160(12):1803-9. PubMed ID: 10871974
    [Abstract] [Full Text] [Related]

  • 5. Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group.
    Farley A, Wruble LD, Humphries TJ.
    Am J Gastroenterol; 2000 Aug 26; 95(8):1894-9. PubMed ID: 10950032
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group.
    Castell DO, Richter JE, Robinson M, Sontag SJ, Haber MM.
    Am J Gastroenterol; 1996 Sep 26; 91(9):1749-57. PubMed ID: 8792693
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis. The Dutch Lansoprazole Study Group.
    Jansen JB, Van Oene JC.
    Aliment Pharmacol Ther; 1999 Dec 26; 13(12):1611-20. PubMed ID: 10594396
    [Abstract] [Full Text] [Related]

  • 12. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
    Campbell DR, Haber MM, Sheldon E, Collis C, Lukasik N, Huang B, Goldstein JL.
    Am J Gastroenterol; 2002 Sep 26; 97(9):2208-14. PubMed ID: 12358234
    [Abstract] [Full Text] [Related]

  • 13. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
    Poynard T, Lemaire M, Agostini H.
    Eur J Gastroenterol Hepatol; 1995 Jul 26; 7(7):661-5. PubMed ID: 8590162
    [Abstract] [Full Text] [Related]

  • 14. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
    Russo A, Dattilo M.
    Ital J Gastroenterol Hepatol; 1997 Aug 26; 29(4):312-9. PubMed ID: 9476183
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A comparison of five maintenance therapies for reflux esophagitis.
    Vigneri S, Termini R, Leandro G, Badalamenti S, Pantalena M, Savarino V, Di Mario F, Battaglia G, Mela GS, Pilotto A.
    N Engl J Med; 1995 Oct 26; 333(17):1106-10. PubMed ID: 7565948
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
    Richter JE, Sabesin SM, Kogut DG, Kerr RM, Wruble LD, Collen MJ.
    Am J Gastroenterol; 1996 Sep 26; 91(9):1766-72. PubMed ID: 8792695
    [Abstract] [Full Text] [Related]

  • 19. Prevention of recurrence of oesophageal stricture, a comparison of lansoprazole and high-dose ranitidine.
    Swarbrick ET, Gough AL, Foster CS, Christian J, Garrett AD, Langworthy CH.
    Eur J Gastroenterol Hepatol; 1996 May 26; 8(5):431-8. PubMed ID: 8804870
    [Abstract] [Full Text] [Related]

  • 20. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D, Paré P, Pericak D, Pyzyk M, Canadian Pantoprazole GERD Study Group.
    Am J Gastroenterol; 2001 Oct 26; 96(10):2849-57. PubMed ID: 11695354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.